औषधि विकास और अनुसंधान के अंतर्राष्ट्रीय जर्नल

  • आईएसएसएन: 0975-9344
  • जर्नल एच-इंडेक्स: 44
  • जर्नल उद्धरण स्कोर: 59.93
  • जर्नल प्रभाव कारक: 48.80
में अनुक्रमित
  • जेनेमिक्स जर्नलसीक
  • चीन राष्ट्रीय ज्ञान अवसंरचना (सीएनकेआई)
  • उद्धरण कारक
  • Scimago
  • रिसर्च जर्नल इंडेक्सिंग की निर्देशिका (डीआरजेआई)
  • ओसीएलसी- वर्ल्डकैट
  • पबलोन्स
  • मियार
  • विश्वविद्यालय अनुदान आयोग
  • यूरो पब
  • गूगल ज्ञानी
  • शेरपा रोमियो
  • गुप्त खोज इंजन लैब्स
  • अनुसंधान गेट
इस पृष्ठ को साझा करें

अमूर्त

Recent Findings and Development of 3D Printing Technology in Pharmaceutical
Formulation Development: An Extensive Review

Sankha Bhattacharya*, Sushil Kumar Singh, Shubham Shrestha, Yudhishthir Singh Baghel, Debalina Maity, Akhil Kumar, Ghanshyam Das Gupta, Raj Kumar Narang, Gaurav Goyal and Sourabh Kosey

Three-dimensional (3D) printing technology is an emerging and flourishing technique which has a tremendous
potential to bring a paradigm shift in the pharmaceutical sector. Basically, 3D printing is a fabrication technique in
which automatically layer-by-layer materials are being deposited to create various design of choice. The primary
objective of this manuscript is to discuss modern methods, techniques, and current trends, polymers of choice and
recent applications of 3D printing technology applying in the pharmaceutical sector. Recently, the FDA has approved
3D printed tablet called Spritam, which brings a tremendous boost in the preparation of fabricated drug delivery
system and personalized medicine. In this review, special importance was given to highlight the challenges and
future perspectives of 3D printed technology in the pharmaceutical sector.